Infectious disease
RSV NP 306-314 (HLA-B*07:02) NPKASLLSL
Product number: EP12231_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide RSV NP 306-314 (HLA-B*07:02) with the amino acid sequence NPKASLLSL is a linear peptidic epitope (epitope ID 45374) studied as part of Nucleoprotein (UniProt:O42053) from Human respiratory syncytial virus and Nucleoprotein (UniProt:P22677) from Orthopneumovirus bovis.
RSV NP 306-314 (HLA-B*07:02) has been studied for immune reactivity in publications and has been tested in T cell assays and MHC ligand assays.
TechData
| Sequence: | NPKASLLSL |
| Gene: | N |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Nucleoprotein |
| UniProt Id: | O42053 |
| IEDB Id: | 45374 |
| Species: | Human respiratory syncytial virus (RSV) |
| Allele: | HLA-B*07:02 |
| Application: | Flow Cytometry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |
Documents
References
van Osch, Thijs L J et al. “Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions.” Journal of thrombosis and haemostasis : JTH vol. 20,12 (2022): 3011-3025. doi:10.1111/jth.15898